However, a study analyzing 427 invasive ductal carcinoma cases found that higher SIRT1 expression in HER2+ tumors correlated with a lower risk of axillary lymph node metastasis (LNM), suggesting a potential tumor-suppressive role in this specific subtype [80]. This evidence concerns the gene ERBB2 and neoplasm.